Protocol-based Immunosuppression
Protocol-Based Immunosuppression is a standardized clinical management strategy within maintenance immunosuppression that prescribes fixed, evidence-based regimens of immunosuppressive agents according to predefined therapeutic algorithms to prevent allograft rejection in solid organ transplant recipients.
169
Publications
8.3K
Citations
1.2K
Authors
353
Institutions
Publications per year
2017–2026
19
169
Tolerogenic immunosuppression for organ transplantation
Thomas E. Starzl, Noriko Murase, Kareem Abu‐Elmagd et al. · The Lancet · 2003 · 499 citations · Full text
Life Sciences, Immunology, Surgery +14
Richard A. Nash, Peter A. McSweeney, Leslie J. Crofford et al. · Blood · 2007 · 264 citations · Full text
Medicine, Hematology, Immunology +15
1–5 of 169
1.2K
6
h-index
6
h-index
5
h-index
5
h-index
4
h-index
1–5 of 1.2K
353

University of Minnesota
Minneapolis, United States
11 h-index
50 publications
2.1K citations
University of Pittsburgh Medical Center
Pittsburgh, United States
9 h-index
42 publications
13K citations
University of Pittsburgh
Pittsburgh, United States
7 h-index
59 publications
6.5K citations
Charité - Universitätsmedizin Berlin
Berlin, Germany
5 h-index
16 publications
417 citations

University of Alberta
Edmonton, Canada
5 h-index
15 publications
2.2K citations
Ludwig-Maximilians-Universität München
Munich, Germany
5 h-index
27 publications
964 citations

University of Cincinnati
Cincinnati, United States
5 h-index
10 publications
815 citations
Massachusetts General Hospital
Boston, United States
5 h-index
13 publications
1.2K citations
1–8 of 353
27 publications · 1.4K citations
22
h-index
Repository · 23 publications · 724 citations
15
h-index
12 publications · 1.3K citations
12
h-index
14 publications · 299 citations
12
h-index
13 publications · 350 citations
12
h-index
1–5